Highly efficient genome editing in hematopoietic stem and progenitor cells
Verhagen, H. J.; Kuijk, C.; Kokke, A. M.; Rutgers, L.; van der Meulen, S.; van Mierlo, G.; VOERMANS, C.; Van den akker, E.
Show abstract
Ribonucleoproteins (RNPs) are frequently applied for therapeutic gene editing as well as fundamental research, because the method is fast, viral free, and does not rely on clonal selection. We evaluated various parameters to genetically engineer human hematopoietic stem progenitor cells (HSPCs) using spCas9-RNPs and achieve gene editing efficiencies up to 80%. We find that single guide RNA (sgRNA) design is critical to achieve high gene editing efficiencies. However, finding effective sgRNAs for HSPCs can be challenging, while the contribution of numerous in silico models is unclear. Here we established a time- and cost-efficient in vitro transcribed sgRNA screening model in K562 cells to identify sgRNAs that are effective in HSPCs using RNP delivery. We show that this simple screening method outperforms all in silico prediction models. Our data demonstrates that most in silico sgRNA prediction models are ineffective and we make recommendations to potentially improve their accuracy. We report that gene editing is equally efficient in distinct CD34+ HSPC subpopulations. Furthermore, no effects on cell proliferation, differentiation or in vitro hematopoietic lineage commitment were observed. Finally, no upregulation of p21 expression was found, suggesting unperturbed HSPC homeostasis. Key pointsO_LIIn vitro transcribed single sgRNAs (IVTsgRNA) screening in K562 outperforms in silico modeling C_LIO_LIHematopoietic stem and progenitor cells are equally targeted by Ribonucleoproteins (RNPs) C_LIO_LIHematopoietic stem and progenitor cells show no induction of p21 expression or effects on differentiation, proliferation and lineage commitment C_LI Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=158 SRC="FIGDIR/small/423329v2_ufig1.gif" ALT="Figure 1"> View larger version (37K): org.highwire.dtl.DTLVardef@279812org.highwire.dtl.DTLVardef@170fe3dorg.highwire.dtl.DTLVardef@1438cdforg.highwire.dtl.DTLVardef@1d5c2ab_HPS_FORMAT_FIGEXP M_FIG C_FIG
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Editing the core region in HPFH deletions alters fetal and adult globin expression for treatment of β-hemoglobinopathies 96%
- Multiplex HDR for Disease and Correction Modeling of SCID by CRISPR Genome Editing in Human HSPCs 95%
- Highly specific chimeric DNA-RNA guided genome editing with enhanced CRISPR-Cas12a system 92%
Similar papers in this journal
- ONE-STEP tagging: a versatile method for rapid site-specific integration by simultaneous reagent delivery 95%
- A multiplexed bioluminescent reporter for sensitive and non-invasive tracking of DNA double strand break repair dynamics in vitro and in vivo 94%
- Optimized nickase- and nuclease-based prime editing in human and mouse cells 94%
Similar papers in this journal
- Clinically Relevant Gene Editing in Hematopoietic Stem Cells for the Treatment of Pyruvate Kinase Deficiency Hemolytic Anemia 97%
- Sort-purification of human CD34+CD90+ cells reduces target cell population and improves lentiviral transduction 96%
- In vitro and In vivo Genetic Disease Modelling via NHEJ precise deletions using CRISPR/Cas9 94%
Similar papers in this journal
- TALEN-mediated intron editing of HSPCs enables transgene expression restricted to the myeloid lineage 96%
- Development and IND-enabling studies of a novel Cas9 genome-edited autologous CD34+ cell therapy to induce fetal hemoglobin for sickle cell disease 96%
- Safety and efficacy study of CRISPR/Cas9 treatment of sickle cell disease in clinically relevant conditions highlights disease-specific response 95%
Similar papers in this journal
- Single-stranded HDR templates with truncated Cas12a binding sequences improve knock-in efficiencies in primary human T cells 95%
- Modeling and Correction of Protein Conformational Disease in iPSC-derived Neurons through Personalized Base Editing 92%
- Base editing strategy allows insertion of the A673T mutation in APP gene to prevent the development of Alzheimer's disease 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.